NCT07520006 2026-04-13Study of NX-5948 in Combination With Other Agents in Adults With B-cell MalignanciesNurix Therapeutics, Inc.Phase 1/2 Not yet recruiting150 enrolled
NCT07003464 2025-06-04Phase II Trial of Zanubrutinib, Obinutuzumab, Bendamustine (ZGB) as First-Line Therapy for Chronic Lymphocytic Leukemia: A Single-Center StudyThe First Hospital of Jilin UniversityPhase 2 Not yet recruiting30 enrolled